Cyclazodone

I’m going to be straight with you — cyclazodone is one of those compounds that made me genuinely uncomfortable to research. Not because the user reports are bad. They’re actually surprisingly positive. It’s because the gap between “people love how this feels” and “we have almost no idea what it does to your body long-term” is wider here than with almost any other nootropic I’ve covered.

Cyclazodone is a potent synthetic stimulant that’s been floating around the research chemical market since 2017. Users compare it favorably to prescription stimulants like Adderall. And its parent compound? Pulled from pharmacies worldwide for destroying people’s livers.

That’s the tension at the heart of this guide. So let’s unpack it honestly.

The Short Version: Cyclazodone is an unregulated synthetic stimulant approximately 3-5x more potent than pemoline. Users report strong focus enhancement and wakefulness rivaling prescription stimulants. However, there are zero published human clinical trials, a plausible hepatotoxicity risk inherited from its parent compound, and anyone using it is essentially a test subject. If you’re considering it, you need to understand exactly what you’re getting into.

What Is Cyclazodone?

Cyclazodone is a synthetic central nervous system stimulant belonging to the 4-oxazolidinone class. It was first synthesized in the early 1960s by researchers at Les Laboratoires Dausse in France as part of efforts to develop novel stimulants related to pemoline — a drug that was once prescribed for ADHD before its market withdrawal.

Structurally, cyclazodone is the N-cyclopropyl derivative of pemoline. That cyclopropyl group is a small but significant molecular tweak — it makes cyclazodone roughly 3-5x more potent than pemoline and appears to broaden its effects across multiple neurotransmitter systems. Despite showing promise in early animal pharmacology studies, it was never developed into an approved pharmaceutical. It sat in obscurity for over fifty years before resurfacing on the research chemical market around 2017.

Here’s what you need to understand upfront: cyclazodone has no FDA evaluation, no approved medical use, and no published human clinical trials. Everything we know about its effects in humans comes from animal studies conducted decades ago and self-reported experiences from the research chemical community. That doesn’t automatically make it dangerous — but it does mean you’re flying without a safety net.

Reality Check: Before reaching for any stimulant — prescription or otherwise — make sure your foundations are solid. Sleep, nutrition, gut health, and stress management account for the vast majority of cognitive performance. A potent research chemical stimulant is not a substitute for getting seven hours of sleep. I learned that the expensive way.

How Does Cyclazodone Work?

Think of your brain’s dopamine and norepinephrine systems as a delivery network. Most nootropics work by either making the delivery trucks run more efficiently (reuptake inhibition) or by building more roads (neuroplasticity). Cyclazodone does something more aggressive — it opens the warehouse doors and pushes more packages out onto the trucks all at once.

The primary mechanism appears to be TAAR1 (Trace Amine-Associated Receptor 1) agonism. When cyclazodone activates TAAR1, it triggers the release of dopamine, norepinephrine, and to a lesser extent serotonin into the synaptic cleft. This is mechanistically similar to how amphetamines work — which explains why users draw direct comparisons between the two.

The parent compound pemoline is primarily dopaminergic with minimal noradrenergic activity, which is why pemoline produced fewer “wired” side effects than traditional stimulants. Cyclazodone’s cyclopropyl modification appears to broaden this profile significantly, adding meaningful noradrenergic stimulation and some serotonergic activity. Some sources also suggest possible reuptake inhibition of these same neurotransmitters, though this is less well-established.

In animal models, cyclazodone demonstrated CNS stimulant and antidepressant effects at least equal to dextroamphetamine, with researchers noting a reportedly favorable therapeutic index compared to most other pemoline derivatives. That’s a meaningful finding — but animal pharmacology from the 1960s is a long way from modern human clinical data.

Pro Tip: Understanding the mechanism matters here more than usual. TAAR1 agonism and monoamine release produce tolerance with repeated use. This isn’t a compound you can take daily without diminishing returns. Build in off-days from the start.

Benefits of Cyclazodone

Let me be clear about the evidence quality here: it’s very limited. There are no randomized controlled trials, no double-blind studies, and no published human data of any kind. What follows is extrapolated from animal pharmacology and self-reported user experiences — the lowest tier of evidence.

That said, the pattern of reports is remarkably consistent.

Enhanced Focus and Concentration. This is the primary reason people seek out cyclazodone, and the most reliably reported effect. Users describe strong, functional focus that allows sustained work on demanding tasks for hours. Multiple reports compare it favorably to prescription modafinil and even amphetamine-based medications, though with a somewhat different subjective quality — less euphoric, more “locked in.”

Wakefulness Promotion. Cyclazodone is a potent wakefulness-promoting agent. Users report effects lasting approximately 6-8 hours, positioning it between modafinil (milder, longer) and amphetamine (stronger, comparable duration) in terms of subjective wakefulness. One user described it as the compound that “absolutely does what you want if you’re trying to function at a decent level and prolong wakefulness.”

Mood and Motivation. The dopaminergic and noradrenergic profile predicts mood-elevating properties, and user reports confirm this. Moderate doses are associated with improved motivation, a sense of well-being, and enhanced drive to initiate and complete tasks.

Verbal Fluency. An interesting and commonly reported benefit — multiple users note enhanced verbal fluency and social confidence. This aligns with what we’d expect from increased dopaminergic transmission in prefrontal circuits involved in language production.

Appetite Suppression. Consistent with its stimulant profile, cyclazodone produces significant appetite reduction. This is listed under “benefits” because some users specifically seek this effect, though it can become a concern with extended use.

Reality Check: Positive user reports are inherently biased — people who had bad experiences are less likely to write detailed reviews. And the research chemical community skews toward individuals with higher risk tolerance. Take the glowing testimonials with appropriate skepticism.

How to Take Cyclazodone

No clinically validated dosage exists. Every number below comes from community reports and should be treated as rough guidance, not medical advice.

Dosage ranges reported by users:

• Threshold: 3-5 mg
• Low/Starting dose: 5 mg
• Moderate: 5-15 mg
• Strong: 15-25 mg
• Heavy (not recommended): 25-30+ mg

Start at 3-5 mg. Seriously. This compound is active at very low doses, and individual responses vary widely. You can always take more tomorrow — you can’t un-take what you already swallowed.

Timing matters. Take it in the morning or early afternoon. With a duration of 6-8 hours, anything after 2 PM risks interfering with sleep. Many users report better and faster absorption on an empty stomach, with onset typically occurring within 30-60 minutes.

Cycling is not optional. Tolerance develops relatively quickly with daily use. The most common protocols are 2-3 days on followed by 2-3 days off, or weekday-only use with weekends off. Full tolerance reduction takes approximately 3-7 days, with return to baseline at 1-2 weeks of abstinence.

Available forms. Cyclazodone is sold primarily as a powder for research purposes. There are no standardized capsule or tablet formulations from legitimate pharmaceutical manufacturers. If you encounter pre-made capsules from an unverified source, approach with extreme caution — you have no way to verify dose accuracy or purity.

Insider Tip: If you’re coming from modafinil or adrafinil and expecting a similar experience, recalibrate your expectations. Cyclazodone is a fundamentally different animal — more potent, more dopaminergic, and with a narrower effective dose range. The “more is better” approach that some people get away with on modafinil can go sideways fast here.

The Side Effects Nobody Warns You About

This section is long on purpose. With an unregulated research chemical, understanding the risks isn’t optional reading — it’s the whole point.

The Liver Question

This is the elephant in the room, and I’m not going to downplay it. Pemoline — cyclazodone’s parent compound — was removed from the market in most countries after being linked to at least 21 cases of liver failure, including fatal outcomes. Pemoline’s hepatotoxicity was idiosyncratic and unpredictable. Patients could take it safely for months or years before sudden onset of liver damage.

Does cyclazodone share this risk? We don’t know. The structural similarity makes it plausible. The cyclopropyl modification might increase or decrease the risk — there’s simply no data. This is the single most important consideration for anyone thinking about using this compound.

Important: If you have any history of liver disease, elevated liver enzymes, or compromised liver function, cyclazodone is an absolute no-go. Period. And if you use this compound, regular liver panel blood tests (ALT/AST) are not a nice-to-have — they’re essential harm reduction.

Common Side Effects

• Elevated heart rate — reported to be more pronounced than with amphetamine, which is notable
• Appetite suppression — can be extreme; forced eating may be necessary
• Dry mouth
• Increased body temperature
• Insomnia — if taken too late in the day
• Bruxism — teeth grinding, especially at higher doses
• Frequent urination

Serious Concerns

• Cardiovascular stress — elevated heart rate and blood pressure make this risky for anyone with heart conditions
• Compulsive redosing — some users report a strong urge to take more, suggesting meaningful abuse potential
• Emotional blunting — reports of reduced empathy and emotional flatness, particularly at higher or sustained doses
• Muscle damage — at least one documented hospital case involving the related compound N-methyl-cyclazodone showed elevated creatine kinase (CK: 2954 U/L) and elevated ALT (104 U/L), indicating both muscle damage and liver stress

Drug Interactions to Avoid

• MAOIs — potentially life-threatening hypertensive crisis. Non-negotiable.
• Other stimulants — additive cardiovascular strain with caffeine, amphetamines, or modafinil
• SSRIs/SNRIs — theoretical serotonin syndrome risk given cyclazodone’s serotonergic activity
• Alcohol — masks intoxication and compounds liver stress
• Hepatotoxic drugs — any additional liver burden increases cumulative risk

Who Should Not Use Cyclazodone

• Anyone with liver disease or elevated liver enzymes
• Anyone with cardiovascular conditions
• Anyone with anxiety disorders (stimulants often make these worse)
• Anyone with a history of substance abuse
• Pregnant or nursing individuals — absolutely not
• Anyone under 18 — no safety data exists

Stacking Cyclazodone

A word of caution before we get into combinations: stacking an unstudied research chemical with other compounds adds layers of unpredictability. Every substance you add is another variable you can’t fully account for.

Commonly reported synergies:

L-Theanine (100-200 mg) is the most logical pairing — it takes the edge off stimulant-induced jitteriness and anxiety without blunting the focus-enhancing effects. This is the same principle behind the classic caffeine + L-theanine stack, applied to a more potent stimulant.

Alpha-GPC (300-600 mg) provides choline to support acetylcholine production alongside the dopaminergic stimulation. Some users report this adds a dimension of mental clarity that cyclazodone alone doesn’t provide.

Harm reduction additions (strongly recommended):

NAC (N-Acetyl Cysteine) (600-1200 mg) — the most commonly recommended liver-protective supplement. NAC supports glutathione production, your body’s primary antioxidant defense in the liver. Given the hepatotoxicity concern, this is arguably non-negotiable if you’re using cyclazodone.

Magnesium (200-400 mg glycinate or threonate) — addresses bruxism and muscle cramps, two common side effects. Magnesium L-threonate has the added benefit of crossing the blood-brain barrier.

What to absolutely avoid combining:

• MAOIs — hypertensive crisis risk
• Adrafinil — compound hepatotoxicity risk (adrafinil is also liver-processed)
• High-dose caffeine — excessive cardiovascular stimulation
• Alcohol — liver stress compounding
• Other potent stimulants — additive cardiac strain

My Take

I’m going to be blunt: I can’t recommend cyclazodone for most people.

That’s not because the user reports are bad — they’re actually impressively consistent and positive for focus and productivity. And it’s not because the compound doesn’t work — by all accounts, it works very well. It’s because the risk-to-information ratio is terrible.

We’re talking about a compound with zero human clinical trials, a parent compound that was pulled for liver toxicity, and a mechanism of action that carries inherent abuse potential. The people using it are essentially running an uncontrolled clinical trial on themselves, with a sample size of one and no monitoring protocol.

If you’re looking for cognitive enhancement and wakefulness promotion, there are options with vastly better safety profiles. Modafinil has decades of clinical data. Phenylpiracetam offers mild stimulation with a well-characterized safety profile. Even caffeine paired with L-theanine gives most people 80% of the focus benefit with essentially zero exotic risk.

If you’ve already made up your mind and you’re going to use cyclazodone regardless of what I say — and I know some of you will — then at minimum: start at the lowest possible dose, cycle rigorously, get baseline liver panels before you start, retest every 4-6 weeks, stack NAC for liver support, and stop immediately if you experience any signs of liver distress (jaundice, dark urine, persistent fatigue, right-side abdominal pain).

This is one of those cases where the foundations-first approach isn’t just philosophy — it’s genuinely the smarter path. Fix your sleep, dial in your nutrition, manage your stress, and reach for well-studied compounds before you start experimenting with research chemicals that nobody fully understands. Your liver will thank you.